Bugedo G, Muñoz H, Torregrosa S, Dagnino J
Departamento de Anestesiología, Hospital Clínico, P Universidad Católica de Chile, Santiago de Chile.
Rev Med Chil. 1995 May;122(5):517-24.
We compared the efficacy and side effects of postoperative continuous infusions versus intermittent intravenous on-demand morphine, with or without the addition of clonixin. Eighty five healthy patients, aged 18 to 65 years, scheduled for elective cholecystectomy, were prospectively randomized: Group 1 (n = 22) received morphine 2.5 mg i.v. on-demand; group 2 (n = 22) received a clonixin 400 mg/day i.v. infusion; group 3 (n = 19) a morphine 0.4 mg/kg/day i.v. infusion; and group 4 (n = 22) received a clonixin 400 mg/day plus a morphine 0.4 mg/kg/day i.v. infusion. Groups 2, 3 and 4 also received, on-demand, 2.5 mg i.v. bolus doses of morphine. A blind observer recorder analogue and descriptive pain scores, respiratory rates and side-effects for 72 hours postoperatively. Groups with morphine infusions had less overall pain scores for the first day when compared with intermittent dosing (p < 0.05); these groups also had less pain during the night (p = 0.0016) and required less additional morphine (p < 0.0001). Side-effects were similar and no cases of heavy sedation or respiratory depression were observed. We conclude that a morphine 0.4 mg/kg/day infusion is a safe and effective alternative to on demand dosing in healthy patients after elective cholecystectomy, achieving better analgesia without increasing side-effects. Clonixin 400 mg/day seems to add no significant benefits.
我们比较了术后持续输注吗啡与静脉按需注射吗啡(加或不加氯尼辛)的疗效和副作用。85名年龄在18至65岁之间、计划进行择期胆囊切除术的健康患者被前瞻性随机分组:第1组(n = 22)按需静脉注射2.5 mg吗啡;第2组(n = 22)静脉输注400 mg/天氯尼辛;第3组(n = 19)静脉输注0.4 mg/kg/天吗啡;第4组(n = 22)静脉输注400 mg/天氯尼辛加0.4 mg/kg/天吗啡。第2、3和4组也按需静脉推注2.5 mg吗啡。一名盲法观察者记录术后72小时的视觉模拟评分和描述性疼痛评分、呼吸频率及副作用。与间歇性给药相比,输注吗啡的组在术后第一天的总体疼痛评分更低(p < 0.05);这些组在夜间的疼痛也更少(p = 0.0016),且所需额外吗啡更少(p < 0.0001)。副作用相似,未观察到重度镇静或呼吸抑制病例。我们得出结论,对于择期胆囊切除术后的健康患者,0.4 mg/kg/天的吗啡输注是一种安全有效的按需给药替代方法,能在不增加副作用的情况下实现更好的镇痛效果。400 mg/天的氯尼辛似乎未带来显著益处。